Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Sanofi Pasteur SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Sanofi Pasteur SA, Medical Devices Deals, 2011 to YTD 2017 10
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Sanofi Enters into Co-Development Agreement with MedImmune 12
Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 13
Sanofi Pasteur Enters into Partnership with Infectious Disease Research Institute 14
Immune Design Enters into Co-Development Agreement with Sanofi Pasteur 15
Sanofi Pasteur Enters Into Agreement With SK Chemicals For Pneumococcal Conjugate Vaccine 16
Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 17
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 18
Sanofi Pasteur Enters Into Co-Development Agreement With Xiamen University For Universal Flu Vaccine 19
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 20
CureVac Enters Into Co-Development Agreement With Sanofi Pasteur 21
Alliance Pharma Extends Distribution Agreement With Sanofi Pasteur For ImmuCyst 22
Sanofi Pasteur Enters Into An Agreement With International Vaccine Institute 23
Licensing Agreements 24
Sanofi Pasteur Expands Licensing Agreement With Vivalis 24
CureVac Enters into Licensing Agreement with Sanofi Pasteur to Develop mRNA-Based Prophylactic Vaccine 25
Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 26
Sanofi Pasteur Enters Into Licensing Agreement With University of California, San Diego 27
Acquisition 28
Sanofi Pasteur Acquires Topaz Pharma For Up To US$207.5 Million 28
Sanofi Pasteur SA – Key Competitors 30
Sanofi Pasteur SA – Key Employees 31
Sanofi Pasteur SA – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 35
Corporate Communications 35
Jun 27, 2017: American Academy of Family Physicians Foundation Launches Highlight on VACCINATIONS 4 TEENS to Help Address Teen Under-Vaccination 35
Product News 36
09/26/2016: BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika 36
06/23/2016: New Four-Strain Influenza Vaccine, VaxigripTetra, regulatory dossier from Sanofi Pasteur now approved in Europe 37
02/02/2016: Sanofi Pasteur To Leverage Its Strong Vaccine Legacy In Hunt For Zika Vaccine 38
Clinical Trials 39
Aug 03, 2016: Vaccine Candidates Protect Against Zika Virus in Rhesus Monkeys 39
Mar 29, 2016: Sanofi Pasteur uses novel technology for development of a 2nd-gen influenza vaccine 40
Other Significant Developments 41
Sep 22, 2016: Sanofi Pasteur invests 300 million pesos to triple production capacity at its plant in Argentina 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Key Facts 2
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Sanofi Pasteur SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Sanofi Pasteur SA, Deals By Therapy Area, 2011 to YTD 2017 9
Sanofi Pasteur SA, Medical Devices Deals, 2011 to YTD 2017 10
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Sanofi Enters into Co-Development Agreement with MedImmune 12
Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 13
Sanofi Pasteur Enters into Partnership with Infectious Disease Research Institute 14
Immune Design Enters into Co-Development Agreement with Sanofi Pasteur 15
Sanofi Pasteur Enters Into Agreement With SK Chemicals For Pneumococcal Conjugate Vaccine 16
Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 17
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 18
Sanofi Pasteur Enters Into Co-Development Agreement With Xiamen University For Universal Flu Vaccine 19
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 20
CureVac Enters Into Co-Development Agreement With Sanofi Pasteur 21
Alliance Pharma Extends Distribution Agreement With Sanofi Pasteur For ImmuCyst 22
Sanofi Pasteur Enters Into An Agreement With International Vaccine Institute 23
Sanofi Pasteur Expands Licensing Agreement With Vivalis 24
CureVac Enters into Licensing Agreement with Sanofi Pasteur to Develop mRNA-Based Prophylactic Vaccine 25
Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 26
Sanofi Pasteur Enters Into Licensing Agreement With University of California, San Diego 27
Sanofi Pasteur Acquires Topaz Pharma For Up To US$207.5 Million 28
Sanofi Pasteur SA, Key Competitors 30
Sanofi Pasteur SA, Key Employees 31
Sanofi Pasteur SA, Other Locations 32
Sanofi Pasteur SA, Subsidiaries 32
Sanofi Pasteur SA, Joint Venture 33